Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial

References

Page 1

	Year	Citations
The Pharmacology and Management of the Vitamin K Antagonists Jack Ansell, Jack Hirsh, L. Poller, CHEST Journal Vitamin K AntagonistsPharmacological StudyMedicineClinical PharmacologyPharmacotherapy	2004	1.5K
On closed testing procedures with special reference to ordered analysis of variance Ruth Marcus, Eric Peritz, K. R. Gabriel Biometrika EngineeringComparative TestClosed Testing ProceduresTest DerivationStatistical Computing	1976	1.4K
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial Bengt I. Eriksson, Ola E. Dahl, Nadia Rosencher, The Lancet ThrombosisVenous DiseaseVenous ThrombosisVersus EnoxaparinHip Arthroplasty	2007	1.1K
Roentgen Diagnosis of Venous Thrombosis in the Leg Keith Rabinov Archives of Surgery Dye InjectionDiagnosisRoentgen DiagnosisInterventional RadiologySurgery	1972	760
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors Norbert Hauel, Herbert Nar, Henning Priepke, Journal of Medicinal Chemistry Chemical BiologyPharmaceutical ChemistryThrombosisMedicinal ChemistryThrombin Inhibition	2002	448
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial Bengt I. Eriksson, O.E. Dahl, Harry R. Büller, Journal of Thrombosis and Haemostasis ThrombopoiesisThrombosisDabigatran EtexilateBlood PlateletMedicine	2004	412
Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement Joachim Stangier, Bengt I. Eriksson, Ola E. Dahl, The Journal of Clinical Pharmacology	2005	290
Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement Giancarlo Agnelli, Alexander T. Cohen, Ola E. Dahl, Thrombosis and Haemostasis	2003	252
Prevention of Deep Vein Thrombosis after Major Knee Surgery - A Randomized, Double-Blind Trial Comparing a Low Molecular Weight Heparin Fragment (Enoxaparin) to Placebo Jacques R. Leclerc, William Geerts, Louis Desjardins, Thrombosis and Haemostasis	1992	225
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study Bengt I. Eriksson, Giancarlo Agnelli, Alexander T. Cohen, Journal of Thrombosis and Haemostasis ThrombopoiesisThrombosisVenous ThrombosisBlood PlateletMedicine	2003	199

Page 1